Agios Pharmaceuticals Inc. Stock
The price for the Agios Pharmaceuticals Inc. stock decreased slightly today. Compared to yesterday there is a change of -€0.400 (-0.900%).
With 7 Buy predictions and not the single Sell prediction the community is currently very high on Agios Pharmaceuticals Inc..
As a result the target price of 48 € shows a slightly positive potential of 10.09% compared to the current price of 43.6 € for Agios Pharmaceuticals Inc..
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Agios Pharmaceuticals Inc. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Agios Pharmaceuticals Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
B****
Cons
?
S********** s********
?
G***** c******* t* c**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Agios Pharmaceuticals Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Agios Pharmaceuticals Inc. | -0.900% | -1.357% | 40.645% | 83.193% | 111.650% | -8.634% | -0.751% |
Ironwood Pharmaceuticals | -5.130% | -5.128% | -6.723% | -45.588% | -45.588% | -39.674% | - |
Novocure Ltd | -2.140% | 0.126% | 6.149% | -52.021% | 39.685% | -89.008% | - |
Iovance Biotherapeutics Inc. | -2.760% | 5.806% | -23.144% | -5.036% | -2.433% | -61.340% | - |
Comments
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its price target raised by analysts at Royal Bank of Canada from $44.00 to $53.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for AGIO provided by MarketBeat
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Show more
Ratings data for AGIO provided by MarketBeat
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its price target lowered by analysts at Royal Bank of Canada from $43.00 to $42.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for AGIO provided by MarketBeat